Standout Papers

Efficacy and safety of sorafenib in patients with advanced hepatoce... 2006 2026 2012 2019 934
  1. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial (2012)
    Jordi Bruix, Jean‐Luc Raoul et al. Journal of Hepatology
  2. Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (2006)
    Ghassan K. Abou‐Alfa, Lawrence H. Schwartz et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 105 standout
Sub-graph 1 of 17

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
58 intermediate papers

Works of M. Moscovici being referenced

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
2012 Standout
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
2006 Standout
and 11 more

Author Peers

Author Last Decade Papers Cites
M. Moscovici 1494 324 453 588 574 20 2.1k
Jiamei Yang 1706 359 523 496 785 48 2.5k
Sheng-Long Ye 956 235 490 323 478 20 2.0k
Gar-Yang Chau 1950 280 625 442 1091 37 2.8k
Jane Koh 832 229 481 225 555 31 1.6k
Laura Ladrón de Guevara 984 139 240 307 625 11 1.5k
D. Voliotis 1342 593 932 659 532 46 2.9k
María José Lechuga 717 661 741 508 225 25 2.2k
Anna Skowrońska 1461 290 702 378 1087 35 2.5k
Jianqiang Cai 1034 469 794 402 605 61 2.4k
Kwok Chi Lam 1007 322 575 233 716 23 1.7k

All Works

Loading papers...

Rankless by CCL
2026